ArticleResearch (Washington, D.C.)2026

IFI44 Promotes Clear Cell Renal Cell Carcinoma Progression via PRDX1 and Predicts Poor Prognosis.

Yipeng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.